Go to Header
Go to Navigation
Go to Content
Go to Footer
Login
Help
中文(繁體)
Research Resources
CUHK UPDates
Theses
Experts List
User Guides
About Us
List of Researchers
> Research Assistant Sze Man LAI
Home
Research Outputs
Researcher Profiles
Department Profiles
Research Areas
Miss LAI Sze Man
Personal Information
Position and Department
Research Assistant
,
Department of Medicine and Therapeutics
CUHK Research Outputs
Bacterial infections in patients with COVID-19: the impact of procalcitonin testing on antibiotics prescription in the real world
(
2024
)
Incidence, epidemiology and outcomes of acute allograft rejection following liver transplantation in Australia
(
2024
)
Long-term use of tenofovir disoproxil fumarate increases fracture risk in elderly patients with chronic hepatitis B
(
2024
)
Nonselective β blocker use does not impact on mortality in patients with hepatocellular carcinoma
(
2024
)
A laboratory parameter-based risk score for predicting liver-related complications in patients with non-alcoholic fatty liver disease
(
2023
)
Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosis
(
2023
)
Clinical Outcomes Following Treatment for COVID-19 With Nirmatrelvir/Ritonavir and Molnupiravir Among Patients Living in Nursing Homes
(
2023
)
Diabetes Mellitus Impacts on the Performance of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B Patients
(
2023
)
Dipeptidyl-peptidase 4 inhibitors improve survival of patients with diabetes mellitus and hepatocellular carcinoma receiving immunotherapy
(
2023
)
Increasing prevalence of high serum hepatitis B virus (HBV) DNA in pregnant ladies: a territory-wide study
(
2023
)
Metformin and immunotherapy in hepatocellular carcinoma: a multi-center retrospective cohort study
(
2023
)
Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss
(
2023
)
Risk of hepatitis B virus reactivation in hepatocellular carcinoma patients with current or past hepatitis B infection receiving immunotherapy: a territory-wide cohort study
(
2023
)
Similar risk of hepatocellular carcinoma in non-cirrhotic patients who achieved HBsAg seroclearance before the age of 50 and the general population
(
2023
)
Trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory-wide study
(
2023
)
Impact of COVID-19 oral antiviral use on the liver biochemistry: a territory-wide cohort study of 33,363 hospitalized COVID-19 patients in Hong Kong
(
2022
)
Impact of the use of oral antiviral agents on the risk of hospitalization in community Coronavirus Disease 2019 Patients (COVID-19)
(
2022
)
Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
(
2022
)
Increasing prevalence of high serum Hepatitis B Virus (HBV) DNA in pregnant ladies: a territory-wide study
(
2022
)
Long-term risk of hepatocellular carcinoma and hepatic decompensation after hepatitis B surface antigen seroclearance: a territory-wide cohort of 9,769 patients
(
2022
)
Overview of methodologies and statistical strategies in observational studies and meta-analyses on the risk of hepatocellular carcinoma in patients with chronic hepatitis B on entecavir or tenofovir therapy
(
2022
)
Risk of hepatocellular carcinoma, but not hepatic decompensation, persists beyond 7 years after hepatitis B surface antigen seroclearance: A territory-wide cohort of 9,769 patients
(
2022
)
Secular trend of the accuracy of hepatocellular carcinoma risk scores in treated chronic hepatitis B patients in 2005–2020: a territory-wide study of 48, 706 subjects
(
2022
)
The discriminatory power of risk scores for hepatocellular carcinoma in treated chronic hepatitis B patients with and without diabetes: a territory-wide study of 48,706 subjects
(
2022
)
Trends in metabolic control and treatment among nonalcoholic fatty liver disease patients with type 2 diabetes between 2000 and 2020: a territory- wide study
(
2022
)
Share Link
Last updated on 2024-03-09 at 16:08
Share Link
Your name*
Your email*
Recipient's name*
Recipient's email*
Message
Auxilliary Information
No information will be stored or shared with any third party.
Cancel
Our policy towards the use of cookies
All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Ok to Continue
Cookie Policy